References
- 1. Timár J, Döme B, Fazekas K, Janovics A, Paku S. Angiogenesis-dependent diseases and angiogenesis therapy. Pathol Oncol Res. 2001; 7: 85-94.10.1007/BF03032573
- 2. Folkman J. Angiogenesis in cancer, rheumatoid and disease. Nat Med. 1995; 1:27-31.10.1038/nm0195-27
- 3. Liekens S, de Clercq E, Neyts J. Angiogenesis Regulators and clinical applications. Biochem Pharmacol. 2001; 61:253-70.10.1016/S0006-2952(00)00529-3
- 4. Eder JP Jr, Supko JG, Clark JW, Puchalski TA, Garcia Carbonero R, Ryan DP, et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol. 2002; 20:3772-84.10.1200/JCO.2002.02.08212228197
- 5. Perletti G, Concari P, Giardini R. Antitumor activity of endostatin against carcinogen-induced rat primary mammary tumors. Cancer Res. 2000; 60:1793-96.
- 6. Sang SM, Lao AN, Wang HC, Chen ZL, Uzawa J, Fujimoto Y. A Phenylpropanoid glycoside from Vaccaria segetalis. Phytochemistry. 1998; 48:569-74.10.1016/S0031-9422(97)00896-0
- 7. Sang S, Lao A, Wang H, Chen Z, Uzawa J, Fujimoto Y. Triterpenoid saponins from Vaccaria segetalis. J Asi Nat Prod Res. 1999; 1:199-211.10.1080/10286029908039865
- 8. Mazza G. Compositional and morphological characteristics of cow cockle (Saponaria Vaccaria) seed, a potential alternative crop. J Agric Food Chem. 1992; 40:1520-33.10.1021/jf00021a009
- 9. Shengmin S, Zenghua X, Shilong M, Aina L, Zhongliang C. Studies on the flavonol glycosides from the seeds of Vaccaria segetalis. China Journal of Chinese Materia Medica. 2000; 25:221-2.
- 10. Kahkonen MP, Hopia AI, Vuorela HJ, Rauha JP, Pihlaja K, Kujala TS, et al. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem. 1999; 47:3954-62.10.1021/jf990146l
- 11. Hood JD, Meininger CJ, Ziche M, Granger HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998; 274:H1054-8.
- 12. Lee HK, Seo IA, Seo E, Seo SY, Lee HJ, Park HT. Netrin-1 induces proliferation of Schwann cells through Unc5b receptor. Biochem Biophys Res Commun. 2007; 362:1057-62.
- 13. Nasr-Esfahani MH, Aboutorabi R, Esfandiari E, Mardani M. Sperm MTT viability assay: a new method for ev aluation of human sperm viability. J Assist Reprod Genet. 2002; 19:477-82.10.1023/A:1020310503143
- 14. Shu Cheng Z, Zhi Kui W, Lei W, Hong Yi W, Jie Dong W. Application of chicken chorioallantoic membrane as a model for study of effects of Chinese medicine on angiogensis. China Journal of Basic Medicine in Traditional Chinese Medicine. 1999; 5:16-9.
- 15. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA, Pauly RR, Grant DS, Martin GR. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest. 1992; 67:519-28.
- 16. Galluscio EH. Retrograde amnesia induced by electroconvulsive shock and carbon dioxide anesthesia in rats: an attempt to stimulate recovery. J Comp Physiol Psychol. 1971; 75:136-40.10.1037/h0030680
- 17. Bouwens L, Lu WG, De Krijger R. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia. 1997; 40:398-404.10.1007/s001250050693
- 18. Becker M, Ingianni G, Lassner F, Atkins D, Schroder JM. Intraoperative histological sections in obstetric brachial plexus lesions-comparison of macroscopic appearance, HE staining and toluidine blue staining. Handchir Mikrochir Plast Chir. 2003; 35:112-6.
- 19. Kerbel R, Folkman J. Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2:727-39.10.1038/nrc905
- 20. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 1999; 13:9-22.
- 21. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem. 1989; 264:20017-24.
- 22. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983; 219:983-5.
- 23. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005; 23:1011-27.10.1200/JCO.2005.06.081
- 24. Dvorak HF. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol. 2002; 20:4368-80.10.1200/JCO.2002.10.088
- 25. Ying-juan W, Ling-di Z, Yu-ling S. Study of VEGFR and its Inhibitors in the Treatment of Tumors. Medical Recapitulate. 2007; 13:1566-68.
- 26. Finzel BC, Poulos TL, Kraut J. Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. J Biol Chem. 1984; 259:13027-36.
- 27. Giles SS, Perfect JR, Cox GM. Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformans. Fungal Genet Biol. 2005; 42:20-9.10.1016/j.fgb.2004.09.003
- 28. Wilson SE, Netto M, Ambrosio R, Jr. Corneal cells: chatty in development, homeostasis, wound healing, and disease. Am J Ophthalmol. 2003; 136:530-6.
- 29. McFarlane S, McNeill L, Holt CE. FGF signaling and target recognition in the developing Xenopus visual system. Neuron. 1995; 15:1017-28.10.1016/0896-6273(95)90091-8
- 30. Yuan G, Jian En G, Qi Hong S. Research progress on platelet-endothelial cell adhesion molecule-1 (PECAM-1). Chin J Cell Mol Immunol. 2005; 21:40-2.
- 31. Cao G, O’Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, et al. Involvementof human PECAM-1 in angiogenesis and in vitro endothelial cellmigration. Physiol Cell Physiol. 2002; 282:1181-90.